Abstract:Here, we present a gene regulation strategy enabling programmable control over eukaryotic translational initiation. By excising the natural poly-adenylation (poly-A) signal of target genes and replacing it with a synthetic control region harboring RNA-binding protein (RBP)-specific aptamers, cap-dependent translation is rendered exclusively dependent on synthetic translation initiation factors (STIFs) containing different RBPs engineered to conditionally associate with different eIF4F-binding proteins (eIFBPs). This modular design framework facilitates the engineering of various gene switches and intracellular sensors responding to many user-defined trigger signals of interest, demonstrating tightly controlled, rapid and reversible regulation of transgene expression in mammalian cells as well as compatibility with various clinically applicable delivery routes of in vivo gene therapy. Therapeutic efficacy was demonstrated in two animal models. To exemplify disease treatments that require on-demand drug secretion, we show that a custom-designed gene switch triggered by the FDA-approved drug grazoprevir can effectively control insulin expression and restore glucose homeostasis in diabetic mice. For diseases that require instantaneous sense-and-response treatment programs, we create highly specific sensors for various subcellularly (mis)localized protein markers (such as cancer-related fusion proteins) and show that translation-based protein sensors can be used either alone or in combination with other cell-state classification strategies to create therapeutic biocomputers driving self-sufficient elimination of tumor cells in mice. This design strategy demonstrates unprecedented flexibility for translational regulation and could form the basis for a novel class of programmable gene therapies in vivo.

Orthogonal Protein-Responsive mRNA Switches for Mammalian Synthetic Biology

Self-feedback loop-containing synthetic mRNA switches for controlled microRNA sensing

Split RNA switch: Programmable and precise control of gene expression by ensemble of pre- and post-translational regulation

Small-molecule-based regulation of RNA-delivered circuits in mammalian cells

Synergetic regulation of translational reading-frame switch by ligand-responsive RNAs in mammalian cells

Synthetic circular RNA switches and circuits that control protein expression in mammalian cells

Repurposing the mammalian RNA-binding protein Musashi-1 as an allosteric translation repressor in bacteria

Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells

Synthetic RNA-based post-transcriptional expression control methods and genetic circuits

Probing the orthogonality and robustness of the mammalian RNA-binding protein Musashi-1 in Escherichia coli

Optogenetic control of RNA function and metabolism using engineered light-switchable RNA-binding proteins

Construction of A Versatile, Programmable RNA-binding Protein using Designer PPR Proteins and Its Application for Splicing Control in Mammalian Cells

Conditional RNA interference in mammalian cells via RNA transactivation

Engineered RNA‐binding Proteins: Studying and Controlling RNA Regulation

Rational design of microRNA-responsive switch for programmable translational control in mammalian cells

Chemically Modified mocRNAs for Highly Efficient Protein Expression in Mammalian Cells

Design and Construction of a Versatile Synthetic Network for Bistable Gene Expression in Mammalian Systems

Controlling heterologous protein synthesis through a plant RNA ThermoSwitch

Split aminoacyl-tRNA synthetases for proximity-induced stop codon suppression

Orthogonal inducible control of Cas13 circuits enables programmable RNA regulation in mammalian cells

A rational blueprint for the design of chemically-controlled protein switches